Jaehde U - Search Results

1

Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients.

Bilal M, Zoller M, Fuhr U, Jaehde U, Ullah S, Liebchen U, Büsker S, Zander J, Babouee Flury B, Taubert M. Bilal M, et al. Among authors: jaehde u. Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0030923. doi: 10.1128/aac.00309-23. Epub 2023 Jun 27. Antimicrob Agents Chemother. 2023. PMID: 37366614 Free PMC article.

2

Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.

Bilal M, Ullah S, Jaehde U, Trueck C, Zaremba D, Wachall B, Wargenau M, Scheidel B, Wiesen MHJ, Gazzaz M, Chen C, Büsker S, Fuhr U, Taubert M, Dokos C. Bilal M, et al. Among authors: jaehde u. Eur J Clin Pharmacol. 2024 May 9. doi: 10.1007/s00228-024-03697-3. Online ahead of print. Eur J Clin Pharmacol. 2024. PMID: 38722350

3

Computational analysis of heat shock proteins and ferroptosis-associated lncRNAs to predict prognosis in acute myeloid leukemia patients.

Ge F, Wang Y, Sharma A, Jaehde U, Essler M, Schmid M, Schmidt-Wolf IGH. Ge F, et al. Among authors: jaehde u. Front Genet. 2023 Aug 1;14:1218276. doi: 10.3389/fgene.2023.1218276. eCollection 2023. Front Genet. 2023. PMID: 37600655 Free PMC article.

4

Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review.

Karsten Dafonte K, Weber L, Chmielewski F, Böhmer AM, Lutz P, Hartmann G, Jaehde U, Coenen M. Karsten Dafonte K, et al. Among authors: jaehde u. Clin Drug Investig. 2023 Jul;43(7):475-502. doi: 10.1007/s40261-023-01289-0. Epub 2023 Jul 18. Clin Drug Investig. 2023. PMID: 37460783 Free PMC article.

5

Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations.

Hertz DL, Joerger M, Bang YJ, Mathijssen RH, Zhou C, Zhang L, Gandara D, Stahl M, Monk BJ, Jaehde U, Beumer JH. Hertz DL, et al. Among authors: jaehde u. Eur J Cancer. 2024 May;202:114024. doi: 10.1016/j.ejca.2024.114024. Epub 2024 Mar 19. Eur J Cancer. 2024. PMID: 38513383 Review.

6

Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt's lymphoma.

Ge F, Wang Y, Sharma A, Yang Y, Liu H, Essler M, Jaehde U, Schmidt-Wolf IGH. Ge F, et al. Among authors: jaehde u. Int J Mol Sci. 2023 Aug 5;24(15):12476. doi: 10.3390/ijms241512476. Int J Mol Sci. 2023. PMID: 37569852 Free PMC article.

7

Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers.

Günther M, Hentschel L, Schuler M, Müller T, Schütte K, Ko YD, Schmidt-Wolf I, Jaehde U. Günther M, et al. Among authors: jaehde u. BMC Cancer. 2023 Jul 5;23(1):629. doi: 10.1186/s12885-023-11115-7. BMC Cancer. 2023. PMID: 37407982 Free PMC article.

8

The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults.

Pazan F, Weiss C, Wehling M; FORTA Expert Panel Members. Pazan F, et al. Drugs Aging. 2023 May;40(5):417-426. doi: 10.1007/s40266-023-01024-6. Epub 2023 May 2. Drugs Aging. 2023. PMID: 37129833 Free PMC article.

9

[Polypharmacy in nursing homes: options to improve drug therapy safety].

Thürmann PA, Bergner S, Jaehde U. Thürmann PA, et al. Among authors: jaehde u. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023 May;66(5):530-539. doi: 10.1007/s00103-023-03694-4. Epub 2023 Apr 12. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023. PMID: 37042988 Review. German.

10

Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer.

Omlin A, Cathomas R, von Amsberg G, Reuter C, Feyerabend S, Loidl W, Boegemann M, Lorch A, Heidenreich A, Tsaur I, Larcher-Senn J, Buck SAJ, Mathijssen RHJ, Jaehde U, Gillessen S, Joerger M. Omlin A, et al. Among authors: jaehde u. Clin Cancer Res. 2023 May 15;29(10):1887-1893. doi: 10.1158/1078-0432.CCR-22-3360. Clin Cancer Res. 2023. PMID: 36917691 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

209 results

Search Page